|
1
|
Mansilla S, Llovera L and Portugal J:
Chemotherapeutic targeting of cell death pathways. Anticancer
Agents Med Chem. 12:226–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rasul A, Song R, Wei W, et al:
Tubeimoside-1 inhibits growth via the induction of cell cycle
arrest and apoptosis in human melanoma A375 cells. Bangladesh J
Pharmacol. 7:150–156. 2012. View Article : Google Scholar
|
|
3
|
Fu L: China Plant Red Data Book: Rare and
Endangered Plants. 1. Science Press; Beijing: 1992
|
|
4
|
Li Q, Xiao M, Guo L, et al: Genetic
diversity and genetic structure of an endangered species,
Trillium tschonoskii. Biochem Genet. 43:445–458. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hayes PY, Lehmann R, Penman K, Kitching W
and De Voss JJ: Steroidal saponins from the roots of Trillium
erectum (Beth root). Phytochemistry. 70:105–113. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yokosuka A and Mimaki Y: Steroidal
glycosides from the underground parts of Trillium erectum
and their cytotoxic activity. Phytochemistry. 69:2724–2730. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ono M, Sugita F, Shigematsu S, et al:
Three new steroid glycosides from the underground parts of
Trillium kamtschaticum. Chem Pharm Bull (Tokyo).
55:1093–1096. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nohara T, Miyahara K and Kawasaki T:
Steroid saponins and sapogenins of underground parts of Trillium
kamtschaticum Pall. II. Pennogenin- and kryptogenin
3-O-glycosides and related compounds. Chem Pharm Bull (Tokyo).
23:872–885. 1975. View Article : Google Scholar
|
|
9
|
Nohara T, Kumamoto F, Miyahara K and
Kawasaki T: Steroid saponins of aerial parts of Paris
tetraphylla A. Gray and of underground parts of Trillium
tschonoskii Maxim. Chem Pharm Bull (Tokyo). 23:1158–1160. 1975.
View Article : Google Scholar
|
|
10
|
Osbourn A, Goss RJ and Field RA: The
saponins: Polar isoprenoids with important and diverse biological
activities. Nat Prod Rep. 28:1261–1268. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fuchs H, Bachran D, Panjideh H, Schellmann
N, Weng A, Melzig MF, Sutherland M and Bachran C: Saponins as tool
for improved targeted tumor therapies. Curr Drug Targets.
10:140–151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang SL, Liu XK, Wu H, Wang HB and Qing C:
Steroidal saponins and cytoxicity of the wild edible
vegetable-Smilacina atropurpurea. Steroids. 74:7–12. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tyagi A, Bhatia N, Condon MS, Bosland MC,
Agarwal C and Agarwal R: Antiproliferative and apoptotic effects of
silibinin in rat prostate cancer cells. Prostate. 53:211–217. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De Luca A, Maiello MR, D'Alessio A,
Pergameno M and Normanno N: The RAS/RAF/MEK/ERK and the PI3K/AKT
signalling pathways: role in cancer pathogenesis and implications
for therapeutic approaches. Expert Opin Ther Targets. 16 Suppl
2:S17–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Güçlü-Ustündaǧ O and Mazza G: Saponins:
properties, applications and processing. Crit Rev Food Sci Nutr.
47:231–258. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen CX, Zhou J, Zhang YT and Zhao YY:
Steroid saponins of aerial parts of Paris polyphylla var.
yunnanensis. Acta Bot Yunnan. 12:323–329. 1990.(In
Chinese).
|
|
17
|
Matsuda H, Pongpiriyadacha Y, Morikawa T,
Kishi A, Kataoka S and Yoshikawa M: Protective effects of steroid
saponins from Paris polyphylla var. yunnanensis on
ethanol- or indomethacin-induced gastric mucosal lesions in rats:
structural requirement for activity and mode of action. Bioorg Med
Chem Lett. 13:1101–1106. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kougan GB, Miyamoto T, Tanaka C, et al:
Steroidal saponins from two species of Dracaena. J Nat Prod.
73:1266–1270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang Y, Cui LJ, Wang Q and Ye WC:
Separation and identification of active constituents of Paris
vietnamensis. Yao Xue Xue Bao. 41:361–364. 2006.(In Chinese).
PubMed/NCBI
|
|
20
|
Zhou BB and Elledge SJ: The DNA damage
response: putting checkpoints in perspective. Nature. 408:433–439.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moelling K, Schad K, Bosse M, Zimmermann S
and Schweneker M: Regulation of Raf-Akt Cross-talk. J Biol Chem.
277:31099–31106. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
